Simple and Practical Mental Health

  • REVIEWS
  • JOIN NOW!
  • MENU
    • Treatments
    • Disorders/ Conditions
    • Side effects
    • Laboratory testing
    • Other topics
    • Expert interviews
  • DAILY EMAILS
  • RESOURCES
    • Practice Guidelines
    • Rating scales and questionnaires
    • Patient handouts
    • BEST books
    • The BEST apps and websites for mental health
    • How to find specific treatments
    • Cannabis resources for patients
    • Risk management
    • E-fax services
  • NEWS
  • CONTACT US
  • ADMINISTRATIVE
    • Reviews of SPMH
    • About us
    • Editorial Board
    • Frequently Asked Questions (FAQ) for our Members (subscribers)
    • Not receiving daily emails?
    • Instructions for Authors
    • Disclosure
  • LOG IN

Valbenazine (Ingrezza®): Basic information

Valbenazine (US Brand name Ingrezza®) is a vesicular monoamine transporter 2 (VMAT2) inhibitor. Here is basic information about this medication.

FDA-approved indications

Treatment of adults with tardive dyskinesia

Dosage

The initial dose is 40 mg once daily orally. After one week, increase the dose to the recommended dose of 80 mg once daily.

Administration and instructions

Valbenazine may be administered with or without food.

In patients with moderate and severe hepatic impairment, recommended dose is 40 mg daily.

Based on tolerability, consider dose reduction for known poor CYP2D6 metabolizers.

Dosage forms and strengths

Capsules: 40 mg and 80 mg

Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.


Related Pages

Prescribing Information for valbenazine (Ingrezza®)

Potential side effects of valbenazine (Ingrezza®) handout

Comparing the VMAT2 inhibitors

Valbenazine (Ingrezza®) and VMAT2


Copyright 2017, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.

Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Google
  • Email

Leave a Reply Cancel reply

Follow us on social media

  • Facebook
  • Linkedin
  • Twitter

Copyright 2015 Rajnish Mago

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.